Table 2 Medications of patients and localizations of stenoses
Medication and localization of stenoses | IPC + sevoflurane (N = 20) | IPC (N = 20) |
|---|---|---|
Angiotensin converting enzyme inhibitor | 9 (45%) | 14 (70%) |
Acetylsalicylic acid | 16 (80%) | 14 (70%) |
Angiotensine 1 antagonist | 4 (20%) | 1 (5%) |
β-adrenergic inhibitor | 13 (65%) | 13 (65%) |
Calcium channel blocking agents | 8 (40%) | 5 (25%) |
Diuretics | 9 (45%) | 4 (20%) |
Digitalis | 0 (0%) | 3 (15%) |
Insulin | 5 (15%) | 1 (5%) |
Oral antidiabetics | 2 (10%) | 4 (20%) |
Statins | 8 (40%) | 10 (50%) |
Platelet aggregation inhibitor | 2 (10%) | 2 (10%) |
Superficial femoral artery | 14 (70%) | 13 (65%) |
Common femoral artery | 12 (60%) | 9 (45%) |
External iliac artery | 7 (35%) | 6 (30%) |
Common iliac artery | 4 (20%) | 5 (25%) |
Profunda femoral artery | 2 (10%) | 2 (10%) |
Internal iliac artery | 1 (5%) | 0 (0%) |